Fadrozole and letrozole in advanced breast cancer: Clinical and biochemical effects

被引：0
|
作者：
Ian E. Smith
Alison Norton
机构：
[1] Royal Marsden Hospital,Breast Unit, Head of Section of Medicine
来源：
Breast Cancer Research and Treatment | 1998年 / 49卷
关键词：
Public Health; Breast Cancer; Advanced Breast; Advanced Breast Cancer; Letrozole;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S67 / S71
相关论文
共 50 条
  • [1] Fadrozole and letrozole in advanced breast cancer: Clinical and biochemical effects
    Smith, IE
    Norton, A
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (Suppl 1) : S67 - S71
  • [2] Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer
    Bonnefoi, HR
    Smith, IE
    Dowsett, M
    Trunet, PF
    Houston, SJ
    daLuz, RJ
    Rubens, RD
    Coombes, RC
    Powles, TJ
    BRITISH JOURNAL OF CANCER, 1996, 73 (04) : 539 - 542
  • [3] Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer
    Tominaga, T
    Adachi, I
    Sasaki, Y
    Tabei, T
    Ikeda, T
    Takatsuka, Y
    Toi, M
    Suwa, T
    Ohashi, Y
    ANNALS OF ONCOLOGY, 2003, 14 (01) : 62 - 70
  • [4] LETROZOLE IN THE TREATMENTOF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2007, 13 (01): : 74 - 76
  • [5] Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK
    Mark Nuijten
    Liebeth Meester
    Franz Waibel
    Suzanne Wait
    PharmacoEconomics, 1999, 16 : 379 - 397
  • [6] Letrozole in advanced breast cancer: the PO25 trial
    Henning T. Mouridsen
    Breast Cancer Research and Treatment, 2007, 105 : 19 - 29
  • [7] Letrozole in advanced breast cancer: the PO25 trial
    Mouridsen, Henning T.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) : 19 - 29
  • [8] Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai
    Gnanaguru, Vijay
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Kalaiarasi, Jayachandran Perumal
    Mehra, Nikita
    Joshi, Archit
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Karunakaran, Parathan
    Ananthi, Balasubramanian
    Iyer, Priya
    Senguttuvan, Geetha
    Rao, Manjula
    Priya, Madhu
    Krishnamurthy, Arvind
    Velusamy, Sridevi
    Raj, Hemanth
    Ranganathan, Rama
    Sundersingh, Shirley
    Kumar, Krishna
    Ganesarajah, Selvaluxmy
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 182 - 186
  • [9] EFFECTS OF FADROZOLE (CGS-16949A) AND LETROZOLE (CGS-20267) ON THE INHIBITION OF AROMATASE-ACTIVITY IN BREAST-CANCER PATIENTS
    DEMERS, LM
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) : 95 - 102
  • [10] Letrozole - A review of its use in postmenopausal women with advanced breast cancer
    Lamb, HM
    Adkins, JC
    DRUGS, 1998, 56 (06) : 1125 - 1140
12345